Link Cell Therapies

linkcelltx.com

Link cell therapies was launched by stanford founders robbie majzner and crystal mackall in partnership with investors samsara biocapital and sheatree capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “and” gates require two cancer-associated targets for a car t cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.